Cart 0
D-Mammose SAP - 50 grams Powder

D-Mammose SAP - 50 grams Powder

Annually, urinary tract infections (UTIs) are responsible for more than 11 million physician visits in the United States. Although normally a commensal inhabitant of the intestinal and gastrointestinal tract of humans, E. coli is the most common urinary tract pathogen, whose overgrowth and over-colonization accounts for 85% of UTIs. Cranberries have been used as a medicinal agent for centuries to promote health, but recently the scientific literature has proven that proanthocyanidins, contained in cranberries, as well as a simple sugar, D‑mannose, specifically inhibit the adhesion and proliferation of E. coli in the urinary tract. Cranberry extracts and D‑mannose each independently inhibit one of two adhesion methods utilized by E. coli. Combined together in a synergistic and novel formula, D‑Mannose SAP addresses both Type 1 (FimH) and P‑Type fimbrial-mediated adhesion by E. coli to the urinary tract mucosa. D‑Mannose SAP is specifically targeted for the treatment and prevention of E. coli UTI.

$34.00

Annually, urinary tract infections (UTIs) are responsible for more than 11 million physician visits in the United States. Although normally a commensal inhabitant of the intestinal and gastrointestinal tract of humans, E. coli is the most common urinary tract pathogen, whose overgrowth and over-colonization accounts for 85% of UTIs. Cranberries have been used as a medicinal agent for centuries to promote health, but recently the scientific literature has proven that proanthocyanidins, contained in cranberries, as well as a simple sugar, D‑mannose, specifically inhibit the adhesion and proliferation of E. coli in the urinary tract. Cranberry extracts and D‑mannose each independently inhibit one of two adhesion methods utilized by E. coli. Combined together in a synergistic and novel formula, D‑Mannose SAP addresses both Type 1 (FimH) and P‑Type fimbrial-mediated adhesion by E. coli to the urinary tract mucosa. D‑Mannose SAP is specifically targeted for the treatment and prevention of E. coli UTI.

Each 5 g (approx. 2½ teaspoons) of D‑Mannose SAP contains: Medicinal ingredient: Cranberry concentrate . . . . . . . . . . . . . . . . . . . . . . . . .   400 mg Non-medicinal ingredient: d-Mannose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4600 mg Contains no: Preservatives, artificial flavour or colour, dairy, starch, wheat, gluten, soy, corn or yeast.

For acute UTI: 1 teaspoon dissolved in water three times daily for two days; followed by 1 teaspoon per day for four days. For UTI Prevention: 1 teaspoon dissolved in water per day. INDICATION D‑Mannose SAP provides therapeutic dosages of both d‑mannose and cranberry extract, both known E. coli adhesion inhibitors in the genitourinary tract. D‑Mannose SAP may be effective for the treatment of acute E. coli urinary tract infections and for the prevention of recurrent urinary tract infections. PURITY, CLEANLINESS AND STABILITY Third party testing on finished product to ensure D‑Mannose SAP is free of heavy metals, pesticides, volatile organics and other impurities.


Share this Product


More from this collection

Sale

Unavailable

Sold Out